Ancient Medicine Meets Modern Trials in Diabetic Kidney Disease Care
Newswise — Diabetic kidney disease affects a growing proportion of people with diabetes and remains the leading cause of end-stage...
trials
Digital Health Technologies Use In Clinical Trials: Support From MAHA And Defined Expectations From FDA’s Final Guidance – Healthcare
Digital health technologies (DHT) are a key aspect of U.S. Health & Human Services (HHS) Secretary Robert F. Kennedy Jr.'s...
Digital health technology use in clinical trials of rare diseases: a systematic review
Over the past few decades, substantial global efforts have been undertaken to advance therapeutic development for rare diseases through supportive...
Implementation of Metformin Therapy to Ease Decline of Kidney Function in Polycystic Kidney Disease (IMPEDE-PKD): study protocol for a phase III, multi-centre, randomized, placebo-controlled trial evaluating the long-term efficacy of metformin in slowing the rate of kidney function decline in patients with autosomal dominant polycystic kidney disease | Trials
Explanation for the choice of comparators {6b}Participants in the control group will receive matched identical placebo. A placebo-controlled trial was...
Funding fuels trials for CareTech Human’s health technology
A Cornell-based startup is advancing a solution that could improve care for the millions of people suffering from urological conditions...
Regulatory considerations for successful implementation of digital endpoints in clinical trials for drug development
Advances in Digital Health Technologies (DHTs) have opened new opportunities in clinical trials by providing innovative methods to collect information...
